Brookwood Investment Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
Brookwood Investment Group's AMGN Position: Q2 2026 in Review
Brookwood Investment Group increased its Amgen (AMGN) stake by 2.9% in Q2 2026, buying an estimated $11.6K and bringing the position to 1,219 shares worth $441K. The position accounts for 0.05% of the portfolio, ranked #328.
Brookwood Investment Group first reported a position in AMGN in Q1 2025 and has held it in 6 quarters since. The position peaked at $453K in Q4 2025. 1,456 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Brookwood Investment Group held 1,219 shares of Amgen worth $441K as of Q2 2026.
- Brookwood Investment Group bought 34 Amgen shares in Q2 2026, an estimated $11.6K.
- Amgen made up 0.05% of Brookwood Investment Group's portfolio in Q2 2026, its #328 holding.
- Brookwood Investment Group first reported a position in Amgen in Q1 2025 and has held it in 6 quarters since.
- Brookwood Investment Group's Amgen position peaked at $453K in Q4 2025.
- 1,456 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Brookwood Investment Group's 13F filing for Q2 2026, filed 23 Jul 2026.